On this page
Update: January 2014
- 10.1 Design of therapeutic regimens in MDR-TB
- 10.2 Selection of anti-TB drugs in MDR-TB regimens
- 10.3 Building a treatment regimen for MDR-TB
- 10.4 Duration of MDR-TB regimens
- 10.5 Follow-up for patients treated for MDR-TB
- 10.6 Management of adverse effects in patients on second-line regimens
- 10.7 Surgery as an adjunctive treatment measure
- 10.8 Management of patients whose treatment failed and palliative care
- 10.9 Special situations
- 10.10 Treatment of extensively drug-resistant TB (XDR-TB)